Episode Details
Back to Episodes
FDA Approves First New Cholesterol Pill | Orlando News
Description
Merck’s groundbreaking new cholesterol drug, Lipfendra, just received FDA approval—marking the first oral treatment in its class that targets a key protein linked to heart disease. With a projected market arrival in weeks, it promises up to 60% LDL reduction for patients, including those with hereditary high cholesterol. As nearly 25% of U.S. adults struggle with elevated “bad” cholesterol—a major stroke and heart attack risk—this could be a game-changer for millions. The American Heart Association applauds the innovation, especially for those where diet and exercise aren’t enough. Lipfendra isn’t just a pill; it’s a vital new weapon in the fight against the nation’s top killer.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/f5a8b8703c502537